Regenerative medicine in Obstetrics & Gynecology: Current status under the Act on the Safety of Regenerative Medicine in Japan

This publication has 37 references indexed in Scilit:

• Current status of platelet-rich plasma therapy under the act on the safety of regenerative medicine in Japan
  Regenerative Therapy, 2023
• Platelet-rich plasma: inconclusive evidence of reproductive outcomes in menopausal women
  Journal of Assisted Reproduction and Genetics, 2022
• Prenatal enzyme replacement therapy for Akp2−/− mice with lethal hypophosphatasia
  Regenerative Therapy, 2021
• Human Mesenchymal Stem Cell Therapy and Other Novel Treatment Approaches for Premature Ovarian Insufficiency
  Reproductive Sciences, 2021
• Use of Intra-uterine Injection of Platelet-rich Plasma (PRP) for Endometrial Receptivity and Thickness: a Literature Review of the Mechanisms of Action
  Reproductive Sciences, 2021
• A narrative review of platelet-rich plasma (PRP) in reproductive medicine
  Journal of Assisted Reproduction and Genetics, 2021
• Preclinical stem cell therapy in fetuses with myelomeningocele: A systematic review and meta‐analysis
  Prenatal Diagnosis, 2020
• Intrauterine administration of platelet‐rich plasma improves embryo implantation by increasing the endometrial thickness in women with repeated implantation failure: A single‐arm self‐controlled trial
  Reproductive Medicine and Biology, 2020
• Japan's challenges of translational regenerative medicine: Act on the safety of regenerative medicine
  Regenerative Therapy, 2016
• New Japanese Initiatives on Stem Cell Therapies
  Cell Stem Cell, 2015